Interferon-γ Low Producer Genotype +874 Overrepresented in Bacillus Calmette-Guerin Nonresponding Children

Background: There are limited reports on the influence of the immune regulatory genotypes on the efficacy of Bacillus Calmette-Guerin (BCG) in man. This study was designed to evaluate the influence of the cytokine genotype interferon (IFN)-γ +874T/A on T cell in vitro assays in BCG nonresponders (negative to either in vivo or in vitro test with purified protein derivative or both). Methods: Ninety healthy children who were without any clinical evidence of the disease, 45 with a BCG-scar and the remaining 45 without scar were assessed for in vitro T cell responses. CD4+ and CD8+ cell counts were measured by flow cytometry. r32kDaBCG (Ag85A-BCG) protein was used to stimulate T cells and IFN-γ cytokine concentration in the cultures were measured by enzyme-linked immunosorbent assay. Polymorphism in IFN-γ (+874T/A) region was detected by amplification refractory mutation system-polymerase chain reaction. Results: T cell subsets were within the normal range in all subjects. Children with TT genotype showed significantly higher antigen-induced IFN-γ (P < 0.001) as compared with those with AT/AA genotype. The highest values were observed in children with TT genotype combined with positive antigen-specific peripheral blood mononuclear cells proliferation. Seventy-five percent of the vaccinated children with TT genotype showed high amounts of stimulated IFN-γ compared with 66% of scar negative and 16% of scar positive but with AA genotype. Conclusions: IFN-γ (+874T/A) polymorphism seemed to be a strong and independent predictor for clinical outcome of both scar-positive and scar-negative children. These results may help in planning future vaccination strategies. The ability to mount in vitro lymphoproliferation did not distinguish the success or failure of BCG vaccination nor predict susceptibility to the disease.

[1]  S. K. Singh,et al.  Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India. , 2007, Tissue antigens.

[2]  L. García,et al.  Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. , 2006, Tuberculosis.

[3]  G. Sumanlatha,et al.  Cell-mediated immune responses in children towards secreted proteins of Mycobacterium bovis BCG. , 2005, Tuberculosis.

[4]  Sunil Kumar,et al.  Tuberculin specific T cell responses in BCG vaccinated children. , 2005, Indian pediatrics.

[5]  T. Aoshi,et al.  Cytotoxic T-lymphocyte-, and helper T-lymphocyte-oriented DNA vaccination. , 2004, DNA and cell biology.

[6]  Alicia González,et al.  Interferon-γ and Interleukin-10 Gene Polymorphisms in Pulmonary Tuberculosis , 2003 .

[7]  M. Newport,et al.  Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. , 2002, The Journal of infectious diseases.

[8]  T. Ottenhoff,et al.  Kinetics of T cell-activation molecules in response to Mycobacterium tuberculosis antigens. , 2002, Memorias do Instituto Oswaldo Cruz.

[9]  C. Caruso,et al.  Genotype frequencies of the +874T-->A single nucleotide polymorphism in the first intron of the interferon-gamma gene in a sample of Sicilian patients affected by tuberculosis. , 2002, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[10]  T. Brewer.  Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  J. Casanova,et al.  Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. , 1998, Science.

[12]  V. Vijayalakshmi,et al.  Cell mediated immunity in children with scar-failure following BCG vaccination. , 1998, Indian pediatrics.

[13]  G. Besra,et al.  Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. , 1997, Science.

[14]  M. Newport,et al.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. , 1996, The New England journal of medicine.

[15]  J. Ellner,et al.  Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guérin in purified protein derivative (PPD)-positive individuals. , 1995, Journal of immunology.

[16]  H. Billman-Jacobe,et al.  T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis , 1994, Infection and immunity.

[17]  Niang,et al.  T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy , 1994, Infection and immunity.

[18]  S. Kaufmann,et al.  The Mycobacterium bovis 32-kilodalton protein antigen induces human cytotoxic T-cell responses , 1994, Infection and immunity.

[19]  V. Vijayalakshmi,et al.  Cell mediated immune responses in BCG vaccinated children. , 1993, Indian pediatrics.

[20]  A. Bradley,et al.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.

[21]  D. Abramowicz,et al.  Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice , 1992, Infection and immunity.

[22]  V. Vijayalakshmi,et al.  A Study Of The Tuberculin Test II : Its Correlation With The In Vitro Humoral Responses , 1990 .

[23]  V. Vijayalakshmi,et al.  A Study Of The Tuberculin Test And Its Correlation With The In Vitro Responses , 1989 .

[24]  R. Koch.  The Etiology of Tuberculosis , 1982 .

[25]  R. Koch.  Classics in infectious diseases. The etiology of tuberculosis: Robert Koch. Berlin, Germany 1882. , 1982, Reviews of infectious diseases.